FDA Flags Possible Link Between GLP-1 Drugs and Rare Vision-Loss Condition

The U.S. Food and Drug Administration has issued a warning that GLP-1 drugs may be associated with a rare condition that can cause vision loss. The agency stresses that the risk appears to be small and that the available data on it is mixed. Even so, the FDA wants patients who take these medications to be aware of the possibility. The notice reflects the agency's effort to keep the public informed while the evidence is still being evaluated.